Articles
 
Email Page
Expert Q&A on Key Updates in BPCIA Litigation
August 2018
Suchira Ghosh
Practical Law Intellectual Property & Technology Journal

Axinn counsel Suchira Ghosh co-authored an article entitled, "Expert Q&A on Key Updates in BPCIA Litigation" for the August/September 2018 issue of Practical Law Intellectual Property & Technology Journal. The article analyzes how the U.S. Supreme Court's decision in Sandoz v. Amgen, Inc. and other judicial interpretations of various provisions of the Biologics Price Competition and Innovation Act of 2009 (BPCIA) over the past year are likely to affect the filing and litigation strategies of biosimilar applicants and biologics manufacturers, and how these cases may impact the development trajectory of the nascent biosimilar industry in the U.S.

Click here to access the article. A subscription is required.